Work, as we’ve known it, has fundamentally changed.
That statement might have sounded dramatic a year or two ago, but you would be naive to deny it today. AI is no longer just augmenting workflows. It is increasingly owning them. The initial wave focused on the obvious entry points such as drafting presentations, summarizing articles, and writing emails. But what started as assistive has quickly evolved into something far more powerful.
AI agents are now executing entire downstream workflows. Not just writing copy for a presentation, but building it. Not just drafting an email, but sending and iterating on it. These systems run asynchronously, improve over time, and are becoming easier to build and deploy by the day.
Startups and smaller organizations are already operating with them across their workflows and are seeing serious gains (including us at Cypris). Large enterprises, expectedly, lag behind, but will inevitably follow. Large enterprises are for the most part subject to their vendors, and those vendors are undergoing massive foundational shifts from traditional software apps to Agentic AI solutions.
Which raises the question:
What does this shift mean for the enterprise tech stack of the future?
The companies that answer this and position themselves correctly will not just be more efficient. They will operate at a fundamentally different pace. In a world where AI compounds progress, speed becomes the ultimate competitive advantage.
From Search to Chat
My perspective comes from the last five years building Cypris, an AI platform for R&D and IP intelligence.
We launched in 2021, before AI meant what it does today. Back then, semantic search was considered cutting edge. Our core value proposition was helping teams identify signals in massive datasets such as patents, research papers, and technical literature faster than their competitors.
The reality of that workflow looked very different than it does today.
Researchers spent the majority of their time on data curation. Entire teams were dedicated to building complex Lucene queries across fragmented datasets. The quality of insights depended heavily on how good your query was, and how effectively you could interpret thousands of results through pre-built charts, visualizations, BI tools and manual workflows.
Work that now takes minutes used to take weeks. Prior art searches, landscape analyses, and whitespace identification all required significant manual effort. Most product comparisons, and ultimately our demos, came down to a few questions:
- Does your query return better results than theirs?
- How robust are your advanced search capabilities?
- What kind of visualizations can you offer to identify meaningful signal in the results?
Then everything changed.
The Inflection Point - When AI Became Exposed to Enterprise
The launch of ChatGPT in November 2022 marked a turning point.
At first, its enterprise impact was not obvious. By early 2024, the shift became undeniable. Marketing workflows were the first to transform. Copywriting went from a differentiated skill to a commodity almost overnight. Then came coding assistants, which have rapidly evolved toward full-stack AI development.
We adapted Cypris in real time, shifting from static, pre-generated insights to dynamic, retrieval-based systems leveraging the world’s most powerful models. We recognized early that the model race was a wave we wanted to ride, so we built the infrastructure to incorporate all leading models directly into our product. What began as an enhancement quickly became the foundation of everything we do.
As the software stack progressed quickly, our customers began scrambling to make sense of it. AI committees formed. IT teams took control of purchasing decisions. Sales cycles lengthened as organizations tried to impose governance on something evolving faster than their processes could handle. We have seen this firsthand, with customers explicitly stating that all AI purchases now need to go through new evaluation and procurement processes.
But there is an underlying tension: Every piece of software is now an AI purchase.
And eventually, enterprises will need to operate that way.
What Should Be Verticalized?
At the center of this transformation and a complicated question most enterprise buyers are struggling with today is:
What can general-purpose AI handle, and where do you need specialized systems?
Most organizations do not answer this theoretically. They learn through experience, use case by use case. And the market hype does not help. There is a growing narrative that companies can “vibe code” their way into rebuilding core systems that underpin processes involving hundreds of stakeholders and millions of dollars in impact.
That is unrealistic.
Call me when a company like J&J decides to replace Salesforce with something built in their team’s free time with some prompts.
A more grounded way to think about it is through a simple principle that consistently holds true:
AI is only as good as what it is exposed to.
A model will generate answers based on the data it can access and the orchestration it is given, whether that is its training data, web content, or additional context you provide.
If you do not give it access to meaningful or proprietary data or thoughtful direction, it will default to generic knowledge.
This creates a growing divide within tech stacks that solely levergage 'commodity AI' vs. 'enterprise enhanced AI'.
Commodity AI vs. Enterprise-Enhanced AI
Commodity AI is the baseline.
It includes foundation models such as ChatGPT, Claude, and Co-Pilot, which run on top of those models, that everyone has access to.
Using them is no longer a competitive advantage. It is table stakes.
If your organization relies on the same tools trained on the same data, your outputs and decisions will begin to look the same as everyone else’s.
Enterprise-enhanced AI is where differentiation happens.
This is what you build on top of the foundation.
It includes:
- Integrating proprietary and high-value datasets
- Layering in domain-specific tools and platforms
- Designing curated workflows that tap into verticalized agents
- Building custom ontologies that interpret how your business operates
- Designing org wide system prompts tailored to existing internal processes
The goal is to amplify foundation models with context they cannot access on their own.
Additionally, enterprises that believe they can simply vibe code their own stack on top of foundation models will eventually run into the same reality that fueled the SaaS boom over the last 20 years. Your job is not to build and maintain software, and doing so will consume far more time and resources than expected. Claude is powerful, and your best vendors are already using it as a foundation. You will get significantly more leverage from it through verticalized and enhanced systems.
Where Data Foundations Especially Matter
In our eyes, nowhere is this more critical than in R&D and IP teams.
Foundation model providers are not focused on maintaining continuously updated datasets of global patents, scientific literature, company data, or chemical compounds. It is too niche and not a strategic priority for them.
But for teams making high-stakes decisions such as:
- What to build
- Where to invest
- Where to file IP
- How to differentiate
That data is essential.
If you rely on generic AI outputs without a strong data foundation, you are making decisions on incomplete information.
In technical domains, incomplete information is a strategic risk.
See our case study on real-world scenario gaps here: https://www.cypris.ai/insights/the-patent-intelligence-gap---a-comparative-analysis-of-verticalized-ai-patent-tools-vs-general-purpose-language-models-for-r-d-decision-making
The New Mandate for Enterprise Leaders
All software vendors will be AI-vendors, so figuring out your strategy, figuring out your security and IT governance, and figuring out your deployment process quickly should be a strategic priority. Focus on real-world signal and critical workflows and find vendors that can turn your commodity AI into enterprise enhanced assets before your competitors do.
We are entering a world where AI itself is no longer the differentiator.
How you implement it is.
The enterprises that recognize this early and build their stacks accordingly will not just keep up.
They will redefine the pace of their industries.
AI in the Workforce: From Commodity AI to Enterprise Enhanced Assets
Writen By:
Steve Hafif , CEO & Co-Founder
Work, as we’ve known it, has fundamentally changed.
That statement might have sounded dramatic a year or two ago, but you would be naive to deny it today. AI is no longer just augmenting workflows. It is increasingly owning them. The initial wave focused on the obvious entry points such as drafting presentations, summarizing articles, and writing emails. But what started as assistive has quickly evolved into something far more powerful.
AI agents are now executing entire downstream workflows. Not just writing copy for a presentation, but building it. Not just drafting an email, but sending and iterating on it. These systems run asynchronously, improve over time, and are becoming easier to build and deploy by the day.
Startups and smaller organizations are already operating with them across their workflows and are seeing serious gains (including us at Cypris). Large enterprises, expectedly, lag behind, but will inevitably follow. Large enterprises are for the most part subject to their vendors, and those vendors are undergoing massive foundational shifts from traditional software apps to Agentic AI solutions.
Which raises the question:
What does this shift mean for the enterprise tech stack of the future?
The companies that answer this and position themselves correctly will not just be more efficient. They will operate at a fundamentally different pace. In a world where AI compounds progress, speed becomes the ultimate competitive advantage.
From Search to Chat
My perspective comes from the last five years building Cypris, an AI platform for R&D and IP intelligence.
We launched in 2021, before AI meant what it does today. Back then, semantic search was considered cutting edge. Our core value proposition was helping teams identify signals in massive datasets such as patents, research papers, and technical literature faster than their competitors.
The reality of that workflow looked very different than it does today.
Researchers spent the majority of their time on data curation. Entire teams were dedicated to building complex Lucene queries across fragmented datasets. The quality of insights depended heavily on how good your query was, and how effectively you could interpret thousands of results through pre-built charts, visualizations, BI tools and manual workflows.
Work that now takes minutes used to take weeks. Prior art searches, landscape analyses, and whitespace identification all required significant manual effort. Most product comparisons, and ultimately our demos, came down to a few questions:
- Does your query return better results than theirs?
- How robust are your advanced search capabilities?
- What kind of visualizations can you offer to identify meaningful signal in the results?
Then everything changed.
The Inflection Point - When AI Became Exposed to Enterprise
The launch of ChatGPT in November 2022 marked a turning point.
At first, its enterprise impact was not obvious. By early 2024, the shift became undeniable. Marketing workflows were the first to transform. Copywriting went from a differentiated skill to a commodity almost overnight. Then came coding assistants, which have rapidly evolved toward full-stack AI development.
We adapted Cypris in real time, shifting from static, pre-generated insights to dynamic, retrieval-based systems leveraging the world’s most powerful models. We recognized early that the model race was a wave we wanted to ride, so we built the infrastructure to incorporate all leading models directly into our product. What began as an enhancement quickly became the foundation of everything we do.
As the software stack progressed quickly, our customers began scrambling to make sense of it. AI committees formed. IT teams took control of purchasing decisions. Sales cycles lengthened as organizations tried to impose governance on something evolving faster than their processes could handle. We have seen this firsthand, with customers explicitly stating that all AI purchases now need to go through new evaluation and procurement processes.
But there is an underlying tension: Every piece of software is now an AI purchase.
And eventually, enterprises will need to operate that way.
What Should Be Verticalized?
At the center of this transformation and a complicated question most enterprise buyers are struggling with today is:
What can general-purpose AI handle, and where do you need specialized systems?
Most organizations do not answer this theoretically. They learn through experience, use case by use case. And the market hype does not help. There is a growing narrative that companies can “vibe code” their way into rebuilding core systems that underpin processes involving hundreds of stakeholders and millions of dollars in impact.
That is unrealistic.
Call me when a company like J&J decides to replace Salesforce with something built in their team’s free time with some prompts.
A more grounded way to think about it is through a simple principle that consistently holds true:
AI is only as good as what it is exposed to.
A model will generate answers based on the data it can access and the orchestration it is given, whether that is its training data, web content, or additional context you provide.
If you do not give it access to meaningful or proprietary data or thoughtful direction, it will default to generic knowledge.
This creates a growing divide within tech stacks that solely levergage 'commodity AI' vs. 'enterprise enhanced AI'.
Commodity AI vs. Enterprise-Enhanced AI
Commodity AI is the baseline.
It includes foundation models such as ChatGPT, Claude, and Co-Pilot, which run on top of those models, that everyone has access to.
Using them is no longer a competitive advantage. It is table stakes.
If your organization relies on the same tools trained on the same data, your outputs and decisions will begin to look the same as everyone else’s.
Enterprise-enhanced AI is where differentiation happens.
This is what you build on top of the foundation.
It includes:
- Integrating proprietary and high-value datasets
- Layering in domain-specific tools and platforms
- Designing curated workflows that tap into verticalized agents
- Building custom ontologies that interpret how your business operates
- Designing org wide system prompts tailored to existing internal processes
The goal is to amplify foundation models with context they cannot access on their own.
Additionally, enterprises that believe they can simply vibe code their own stack on top of foundation models will eventually run into the same reality that fueled the SaaS boom over the last 20 years. Your job is not to build and maintain software, and doing so will consume far more time and resources than expected. Claude is powerful, and your best vendors are already using it as a foundation. You will get significantly more leverage from it through verticalized and enhanced systems.
Where Data Foundations Especially Matter
In our eyes, nowhere is this more critical than in R&D and IP teams.
Foundation model providers are not focused on maintaining continuously updated datasets of global patents, scientific literature, company data, or chemical compounds. It is too niche and not a strategic priority for them.
But for teams making high-stakes decisions such as:
- What to build
- Where to invest
- Where to file IP
- How to differentiate
That data is essential.
If you rely on generic AI outputs without a strong data foundation, you are making decisions on incomplete information.
In technical domains, incomplete information is a strategic risk.
See our case study on real-world scenario gaps here: https://www.cypris.ai/insights/the-patent-intelligence-gap---a-comparative-analysis-of-verticalized-ai-patent-tools-vs-general-purpose-language-models-for-r-d-decision-making
The New Mandate for Enterprise Leaders
All software vendors will be AI-vendors, so figuring out your strategy, figuring out your security and IT governance, and figuring out your deployment process quickly should be a strategic priority. Focus on real-world signal and critical workflows and find vendors that can turn your commodity AI into enterprise enhanced assets before your competitors do.
We are entering a world where AI itself is no longer the differentiator.
How you implement it is.
The enterprises that recognize this early and build their stacks accordingly will not just keep up.
They will redefine the pace of their industries.
Keep Reading
Clarivate is not a single product. It is a portfolio of acquired tools assembled over decades, and the two platforms that enterprise R&D teams use most frequently — Derwent Innovation for patent intelligence and Web of Science for scientific literature — were designed for entirely different audiences with entirely different workflows. Derwent was built for IP attorneys conducting freedom-to-operate searches. Web of Science was built for academic librarians and university researchers. Neither was built for the R&D scientist trying to answer a strategic question about a technology landscape, a competitive portfolio, or an emerging technical risk.
The gap between what Clarivate's R&D-adjacent tools were designed to do and what modern innovation teams actually need is the primary reason organizations are evaluating alternatives. This guide examines six of the strongest alternatives to Clarivate for enterprise R&D and IP teams, explains what distinguishes each platform, and provides a framework for matching your team's specific requirements to the right solution.
Why R&D Teams Are Reevaluating Clarivate
Clarivate's position in the market is the product of consolidation, not native product design. The company was spun out of Thomson Reuters' IP and Science division in 2016 and has since assembled its portfolio through a series of acquisitions — Derwent, Web of Science, ProQuest, Cortellis, and others — without fully integrating the underlying data architectures. For R&D teams, the practical consequence is that patent intelligence and scientific literature intelligence live in separate platforms with separate subscriptions, separate interfaces, and separate learning curves.
This fragmentation has real costs. An R&D scientist conducting a technology scouting exercise needs to understand what has been patented, what has been published in the scientific literature, and how those two bodies of knowledge relate to each other. Performing that analysis through Derwent and Web of Science requires toggling between platforms, manually reconciling results, and building synthesis layers that neither tool provides natively. The time investment alone is a meaningful barrier, and the cognitive load of maintaining fluency in two complex legacy interfaces reduces the frequency with which R&D teams can turn to patent and literature intelligence for decision support.
Pricing is a compounding factor. Clarivate's enterprise contracts for combined Derwent and Web of Science access can run into six figures annually, and the terms typically require institutional commitment rather than flexible per-seat or usage-based arrangements. For Fortune 500 R&D organizations that have historically lived with the cost because no integrated alternative existed, the rapid maturation of AI-native intelligence platforms over the past three years has changed the evaluation calculus significantly.
There is also a structural concern specific to Derwent. Clarivate's Derwent World Patents Index is maintained by a team of over 800 patent editors who manually write abstracts for each invention family — a curation model that represents both the platform's greatest strength and its most significant vulnerability. The value of Derwent has always rested on human expertise applied at scale. As AI-native platforms develop increasingly sophisticated capabilities for patent comprehension and synthesis, the competitive differentiation of hand-written abstracts is narrowing, and the cost premium associated with that curation model becomes harder to justify for teams whose primary need is strategic intelligence rather than legal-quality prior art analysis.
What to Look for in a Clarivate Alternative
Before evaluating specific platforms, it is worth being precise about what Clarivate's R&D-adjacent products actually do, because the alternatives that best address those functions are not necessarily the platforms that appear most often in head-to-head comparison articles.
Derwent Innovation provides access to the Derwent World Patents Index, a curated database covering over 130 million patents, along with tools for patent search, analytics, portfolio management, and competitive landscaping. Its primary design center is the patent professional: the interface and workflows are optimized for freedom-to-operate analyses, patentability assessments, and portfolio strategy decisions that require high-confidence data quality.
Web of Science provides access to a peer-reviewed scientific literature database covering approximately 20,000 journals, along with citation analytics, research performance metrics, and discovery tools. Its primary design center is the academic researcher and institutional library administrator.
An effective Clarivate alternative for an enterprise R&D team needs to cover both functions, ideally within a unified architecture, and needs to provide the kind of strategic synthesis and workflow integration that neither Derwent nor Web of Science was designed to deliver. The evaluation criteria that matter most are unified data architecture, native AI capabilities, scientific literature depth alongside patent coverage, enterprise security posture, and whether the platform was designed for R&D scientists and innovation strategists or for IP attorneys and academic administrators.
The Best Clarivate Alternatives for Enterprise R&D Teams
Cypris — Best Unified Platform for Enterprise R&D Intelligence
Cypris takes a fundamentally different approach to R&D intelligence than Clarivate's two-platform model. Rather than providing a patent database and a literature database as separate tools, Cypris unifies over 500 million patents and scientific papers within a single platform, structured through a proprietary R&D ontology that understands the relationships between technical concepts across both corpora. The result is that searches and analyses performed in Cypris return integrated results from patents and scientific literature simultaneously, without requiring the researcher to reconcile findings from separate systems.
The distinction is not merely a user experience improvement. When patent data and scientific literature are indexed through a shared ontology rather than maintained in separate silos, the analytical possibilities expand substantially. A technology scouting exercise can reveal not just what has been patented in a domain but what the concurrent scientific literature suggests about the direction of technical development, where the patent portfolio is leading versus lagging the research frontier, and which organizations are accumulating both IP and publication activity in emerging areas. These cross-signal insights are structurally unavailable in a Derwent-plus-Web-of-Science architecture because the data models do not share a common semantic layer.
Cypris is trusted by hundreds of enterprise teams and thousands of researchers across R&D, IP, and product development functions, including organizations in the Fortune 500. The platform's AI architecture is built on official enterprise API partnerships with OpenAI, Anthropic, and Google — partnerships that distinguish it from platforms that have layered general-purpose AI onto legacy data infrastructure without formal integration agreements. Enterprise security meets Fortune 500 requirements, addressing the compliance and data governance requirements that govern platform adoption decisions at large corporations.
For organizations that have historically maintained separate Derwent and Web of Science subscriptions, Cypris offers the possibility of consolidating that intelligence infrastructure into a single platform while simultaneously gaining access to AI capabilities that neither legacy tool provides. The platform's Research Brief service extends beyond self-service search to provide bespoke analysis by Cypris research analysts, which addresses the capacity constraint that limits how frequently in-house teams can conduct deep landscape analyses.
Google Patents — Best Free Option for Preliminary Research
Google Patents provides free access to patent documents from major patent offices worldwide, with an interface that will be immediately familiar to anyone comfortable with Google's search products. The platform indexes over 87 million patents and offers some integration with Google Scholar to bring non-patent literature into search results.
For preliminary research, competitive screening, and exploratory work, Google Patents offers genuine utility. The familiar search interface eliminates the training investment required by Derwent and Orbit, and the zero-cost access model makes it available to anyone in an R&D organization without procurement friction. Translation capabilities allow English-language searches to surface relevant patents from non-English-language jurisdictions, which addresses one of the more significant practical limitations of manual prior art searching.
The gap between Google Patents and enterprise-grade intelligence platforms is most visible in the analytics layer. Google Patents is a document retrieval tool. It does not offer patent landscaping, portfolio analytics, competitive benchmarking, or AI-powered synthesis — the capabilities that allow R&D teams to extract strategic insights from patent data rather than simply locating relevant documents. For organizations that have been paying Clarivate prices, the step down to Google Patents represents a significant reduction in capability even as it eliminates license costs entirely. It functions well as a complement to an enterprise platform for quick searches, but not as a replacement for the strategic intelligence that Derwent and Web of Science provide in combination.
The Lens — Best Free Platform for Combined Patent and Literature Access
The Lens is the most capable free alternative for organizations that need both patent and scientific literature access without a commercial subscription. The platform provides open access to over 300 million patent records and more than 200 million scientific documents, making it the most comprehensive free resource available for the combined research task that Derwent and Web of Science together currently serve
What distinguishes The Lens from other free tools is its integration philosophy. Patent records and scholarly works are available within the same interface, and The Lens supports citation analysis linking patents to the scientific literature they cite and vice versa. This cross-domain citation capability partially replicates one of the most valuable analytical functions in a combined Derwent and Web of Science environment — understanding how patent filings and published research co-evolve in a technology area.
The Lens operates under an open-access mission and is supported by charitable foundations rather than commercial subscription revenue, which means its development roadmap and feature investment are less predictable than those of commercial platforms. The analytical tools are more limited than those available in Orbit or enterprise platforms, and there is no AI-powered synthesis capability comparable to what modern commercial platforms provide. For budget-constrained teams or organizations beginning to build a patent and literature intelligence practice before committing to enterprise platform investments, The Lens represents a meaningful option. It is not a direct substitute for the combined capability of Clarivate's R&D suite, but it provides a more complete free alternative than any other single platform.
PQAI — Best Open-Source AI Patent Search
PQAI is an open-source patent search platform built on an AI-first philosophy that removes the requirement for Boolean search expertise. Researchers can submit queries in natural language and receive relevant patent results without building complex search strings or learning classification system syntax. The platform includes a prior art search API that allows R&D and legal teams to embed patent intelligence directly into their workflows rather than requiring researchers to visit a separate interface.
For organizations where the primary limitation of Derwent and other legacy platforms has been the training barrier — the reality that effective use requires significant investment in Boolean search and classification system expertise — PQAI offers a genuinely different user experience. Its accessibility makes patent intelligence available to R&D scientists who would not typically engage with Derwent's professional-grade interface.
PQAI's scope is narrower than Clarivate's R&D suite. It does not include scientific literature, and its analytical capabilities are more limited than those of commercial platforms. It is most appropriately used as a prior art search and patent discovery tool rather than as a strategic intelligence platform. PQAI fits best in organizations where patent accessibility is the primary unmet need and where the R&D intelligence use case is being built incrementally rather than addressed through a comprehensive platform investment.
Scite — Best for Citation Intelligence
Scite addresses the scientific literature dimension of the Clarivate suite more directly than any other alternative on this list. The platform provides access to over 1.2 billion citation statements from the scientific literature, with AI-powered analysis of whether each citation supports, contrasts, or simply mentions the cited work. This distinction between supporting and contrasting citations transforms citation analysis from a quantitative measure of research influence into a qualitative map of scientific consensus and controversy — a capability that Web of Science's citation analytics does not provide.
For R&D teams whose primary use of Web of Science is tracking the scientific literature in their technology domains, understanding where expert consensus is solidifying versus where debates remain open, and identifying emerging research directions before they appear in patent filings, Scite's citation intelligence capability offers something meaningfully different from what Web of Science delivers. It is a tool oriented around scientific understanding rather than research performance metrics.
Scite does not address the patent dimension of the Clarivate use case, and its data coverage, while extensive, is focused on the scholarly literature rather than the full breadth of technical documentation that platforms like Cypris access. Organizations replacing a combined Derwent and Web of Science subscription will need to address the patent intelligence requirement separately if they select Scite for the literature component. It is most appropriately positioned as a supplement to an enterprise intelligence platform or as a specialized tool for scientific literature analysis within a broader technology monitoring program.
Choosing the Right Alternative
The right Clarivate alternative depends on which parts of the R&D intelligence workflow the current Clarivate subscription is actually serving and what the primary failure modes of the existing setup are.
For organizations that use Derwent and Web of Science as integrated inputs into technology scouting, competitive landscape analysis, and R&D investment decisions, the most important criterion is unified data architecture. Platforms that treat patents and scientific literature as separate databases with separate interfaces recreate the fragmentation that makes Clarivate's two-platform model difficult to use efficiently. The relevant question is not which alternative is best at patents and which is best at literature, but which alternative treats them as components of a single intelligence layer.
For organizations that use Clarivate primarily for patent prosecution support, freedom-to-operate analysis, and legal-quality prior art searching, the relevant alternatives are different. The data quality and curation precision of Derwent's human-written abstracts matter significantly for legal applications in ways they do not for strategic R&D applications, and the evaluation should weight Orbit Intelligence's capabilities more heavily.
For organizations with constrained budgets exploring their options before committing to enterprise platform investments, the combination of The Lens for free patent and literature access and Scite for citation intelligence provides a meaningful foundation. Neither platform alone replicates Clarivate's combined capability, but together they address the core discovery and analysis functions at no cost.
The broader pattern in how enterprise R&D teams are evaluating this market is a shift toward platforms that were designed for scientists and innovation strategists rather than platforms originally designed for attorneys and academic administrators. Clarivate's core products are genuinely excellent at what they were built to do. The question organizations are asking is whether what they were built to do maps onto what modern enterprise R&D functions actually need — and increasingly, the answer is that the fit is incomplete.
Frequently Asked Questions
What is Clarivate used for in enterprise R&D?
In enterprise R&D contexts, Clarivate is most commonly used through two products: Derwent Innovation for patent search and analytics, and Web of Science for scientific literature access and citation analysis. R&D teams use these tools for technology scouting, competitive landscape analysis, prior art research, and tracking the scientific literature in their technology domains. Because these products are sold as separate subscriptions with separate interfaces, organizations often maintain both to cover the full range of patent and literature intelligence tasks, which creates workflow fragmentation and a combined cost that enterprise R&D teams are increasingly questioning as AI-native unified platforms have matured.
How does Derwent Innovation compare to other patent platforms?
Derwent Innovation's primary differentiator is the Derwent World Patents Index, a curated database in which human patent editors write standardized abstracts for each invention family. These hand-written abstracts improve search precision and patent comprehension, particularly in complex technical domains. The platform covers over 130 million patents and is used by more than 40 national patent offices. Its limitations relative to modern alternatives include a traditional interface designed for IP attorneys rather than R&D scientists, the absence of native scientific literature integration, and a cost structure that reflects its premium data curation model. AI-native platforms increasingly challenge its differentiation by offering sophisticated natural language search and synthesis capabilities that reduce the practical advantage of manually curated abstracts for strategic R&D applications.
Is there a free alternative to Clarivate for R&D research?
The Lens provides the most comprehensive free alternative for the combined patent and scientific literature access that Derwent and Web of Science together currently serve. It covers over 300 million patent records and more than 200 million scholarly documents within a single interface and supports citation analysis linking patents to the scientific literature they cite. PQAI is a capable free option specifically for prior art patent search using natural language queries. Google Patents remains useful for preliminary patent research. None of these free options replicates the analytical capabilities and AI-powered synthesis available in enterprise platforms, but they provide meaningful starting points for organizations building their R&D intelligence practice.
Why are R&D teams replacing Clarivate with AI-native platforms?
The primary reasons R&D teams are evaluating AI-native alternatives to Clarivate center on three limitations of the current platform architecture. First, Derwent and Web of Science are separate products that do not share a unified data model, which requires manual synthesis when both patent and literature intelligence are needed for the same analysis. Second, both platforms were designed for IP attorneys and academic researchers respectively, and their interfaces and analytical tools reflect those use cases rather than the workflow of an R&D scientist or innovation strategist. Third, AI-native platforms have developed sufficient capability in natural language patent search, landscape synthesis, and cross-domain analysis to reduce the competitive advantage of Derwent's manual curation model for strategic R&D applications, while offering workflow integration and AI synthesis capabilities that Clarivate's tools do not provide.
What should enterprise teams prioritize when evaluating Clarivate alternatives?
Enterprise teams should prioritize unified data architecture above other criteria when evaluating Clarivate alternatives. Platforms that treat patents and scientific literature as separate data sources with separate interfaces recreate the fragmentation problem that is the primary operational limitation of the Clarivate suite. After data architecture, the relevant evaluation criteria are native AI capabilities and the quality of synthesis they enable, enterprise security posture and compliance certifications, scientific literature depth alongside patent coverage, and whether the platform's design orientation matches the actual users — R&D scientists and innovation strategists rather than IP attorneys. Cost structure and contract flexibility are also significant considerations given the high annual cost of Clarivate enterprise subscriptions.
Executive Summary
In 2024, US patent infringement jury verdicts totaled $4.19 billion across 72 cases. Twelve individual verdicts exceeded $100million. The largest single award—$857 million in General Access Solutions v.Cellco Partnership (Verizon)—exceeded the annual R&D budget of many mid-market technology companies. In the first half of 2025 alone, total damages reached an additional $1.91 billion.
The consequences of incomplete patent intelligence are not abstract. In what has become one of the most instructive IP disputes in recent history, Masimo’s pulse oximetry patents triggered a US import ban on certain Apple Watch models, forcing Apple to disable its blood oxygen feature across an entire product line, halt domestic sales of affected models, invest in a hardware redesign, and ultimately face a $634 million jury verdict in November 2025. Apple—a company with one of the most sophisticated intellectual property organizations on earth—spent years in litigation over technology it might have designed around during development.
For organizations with fewer resources than Apple, the risk calculus is starker. A mid-size materials company, a university spinout, or a defense contractor developing next-generation battery technology cannot absorb a nine-figure verdict or a multi-year injunction. For these organizations, the patent landscape analysis conducted during the development phase is the primary risk mitigation mechanism. The quality of that analysis is not a matter of convenience. It is a matter of survival.
And yet, a growing number of R&D and IP teams are conducting that analysis using general-purpose AI tools—ChatGPT, Claude, Microsoft Co-Pilot—that were never designed for patent intelligence and are structurally incapable of delivering it.
This report presents the findings of a controlled comparison study in which identical patent landscape queries were submitted to four AI-powered tools: Cypris (a purpose-built R&D intelligence platform),ChatGPT (OpenAI), Claude (Anthropic), and Microsoft Co-Pilot. Two technology domains were tested: solid-state lithium-sulfur battery electrolytes using garnet-type LLZO ceramic materials (freedom-to-operate analysis), and bio-based polyamide synthesis from castor oil derivatives (competitive intelligence).
The results reveal a significant and structurally persistent gap. In Test 1, Cypris identified over 40 active US patents and published applications with granular FTO risk assessments. Claude identified 12. ChatGPT identified 7, several with fabricated attribution. Co-Pilot identified 4. Among the patents surfaced exclusively by Cypris were filings rated as “Very High” FTO risk that directly claim the technology architecture described in the query. In Test 2, Cypris cited over 100 individual patent filings with full attribution to substantiate its competitive landscape rankings. No general-purpose model cited a single patent number.
The most active sectors for patent enforcement—semiconductors, AI, biopharma, and advanced materials—are the same sectors where R&D teams are most likely to adopt AI tools for intelligence workflows. The findings of this report have direct implications for any organization using general-purpose AI to inform patent strategy, competitive intelligence, or R&D investment decisions.
1. Methodology
A single patent landscape query was submitted verbatim to each tool on March 27, 2026. No follow-up prompts, clarifications, or iterative refinements were provided. Each tool received one opportunity to respond, mirroring the workflow of a practitioner running an initial landscape scan.
1.1 Query
Identify all active US patents and published applications filed in the last 5 years related to solid-state lithium-sulfur battery electrolytes using garnet-type ceramic materials. For each, provide the assignee, filing date, key claims, and current legal status. Highlight any patents that could pose freedom-to-operate risks for a company developing a Li₇La₃Zr₂O₁₂(LLZO)-based composite electrolyte with a polymer interlayer.
1.2 Tools Evaluated
1.3 Evaluation Criteria
Each response was assessed across six dimensions: (1) number of relevant patents identified, (2) accuracy of assignee attribution,(3) completeness of filing metadata (dates, legal status), (4) depth of claim analysis relative to the proposed technology, (5) quality of FTO risk stratification, and (6) presence of actionable design-around or strategic guidance.
2. Findings
2.1 Coverage Gap
The most significant finding is the scale of the coverage differential. Cypris identified over 40 active US patents and published applications spanning LLZO-polymer composite electrolytes, garnet interface modification, polymer interlayer architectures, lithium-sulfur specific filings, and adjacent ceramic composite patents. The results were organized by technology category with per-patent FTO risk ratings.
Claude identified 12 patents organized in a four-tier risk framework. Its analysis was structurally sound and correctly flagged the two highest-risk filings (Solid Energies US 11,967,678 and the LLZO nanofiber multilayer US 11,923,501). It also identified the University ofMaryland/ Wachsman portfolio as a concentration risk and noted the NASA SABERS portfolio as a licensing opportunity. However, it missed the majority of the landscape, including the entire Corning portfolio, GM's interlayer patents, theKorea Institute of Energy Research three-layer architecture, and the HonHai/SolidEdge lithium-sulfur specific filing.
ChatGPT identified 7 patents, but the quality of attribution was inconsistent. It listed assignees as "Likely DOE /national lab ecosystem" and "Likely startup / defense contractor cluster" for two filings—language that indicates the model was inferring rather than retrieving assignee data. In a freedom-to-operate context, an unverified assignee attribution is functionally equivalent to no attribution, as it cannot support a licensing inquiry or risk assessment.
Co-Pilot identified 4 US patents. Its output was the most limited in scope, missing the Solid Energies portfolio entirely, theUMD/ Wachsman portfolio, Gelion/ Johnson Matthey, NASA SABERS, and all Li-S specific LLZO filings.
2.2 Critical Patents Missed by Public Models
The following table presents patents identified exclusively by Cypris that were rated as High or Very High FTO risk for the proposed technology architecture. None were surfaced by any general-purpose model.
2.3 Patent Fencing: The Solid Energies Portfolio
Cypris identified a coordinated patent fencing strategy by Solid Energies, Inc. that no general-purpose model detected at scale. Solid Energies holds at least four granted US patents and one published application covering LLZO-polymer composite electrolytes across compositions(US-12463245-B2), gradient architectures (US-12283655-B2), electrode integration (US-12463249-B2), and manufacturing processes (US-20230035720-A1). Claude identified one Solid Energies patent (US 11,967,678) and correctly rated it as the highest-priority FTO concern but did not surface the broader portfolio. ChatGPT and Co-Pilot identified zero Solid Energies filings.
The practical significance is that a company relying on any individual patent hit would underestimate the scope of Solid Energies' IP position. The fencing strategy—covering the composition, the architecture, the electrode integration, and the manufacturing method—means that identifying a single design-around for one patent does not resolve the FTO exposure from the portfolio as a whole. This is the kind of strategic insight that requires seeing the full picture, which no general-purpose model delivered
2.4 Assignee Attribution Quality
ChatGPT's response included at least two instances of fabricated or unverifiable assignee attributions. For US 11,367,895 B1, the listed assignee was "Likely startup / defense contractor cluster." For US 2021/0202983 A1, the assignee was described as "Likely DOE / national lab ecosystem." In both cases, the model appears to have inferred the assignee from contextual patterns in its training data rather than retrieving the information from patent records.
In any operational IP workflow, assignee identity is foundational. It determines licensing strategy, litigation risk, and competitive positioning. A fabricated assignee is more dangerous than a missing one because it creates an illusion of completeness that discourages further investigation. An R&D team receiving this output might reasonably conclude that the landscape analysis is finished when it is not.
3. Structural Limitations of General-Purpose Models for Patent Intelligence
3.1 Training Data Is Not Patent Data
Large language models are trained on web-scraped text. Their knowledge of the patent record is derived from whatever fragments appeared in their training corpus: blog posts mentioning filings, news articles about litigation, snippets of Google Patents pages that were crawlable at the time of data collection. They do not have systematic, structured access to the USPTO database. They cannot query patent classification codes, parse claim language against a specific technology architecture, or verify whether a patent has been assigned, abandoned, or subjected to terminal disclaimer since their training data was collected.
This is not a limitation that improves with scale. A larger training corpus does not produce systematic patent coverage; it produces a larger but still arbitrary sampling of the patent record. The result is that general-purpose models will consistently surface well-known patents from heavily discussed assignees (QuantumScape, for example, appeared in most responses) while missing commercially significant filings from less publicly visible entities (Solid Energies, Korea Institute of EnergyResearch, Shenzhen Solid Advanced Materials).
3.2 The Web Is Closing to Model Scrapers
The data access problem is structural and worsening. As of mid-2025, Cloudflare reported that among the top 10,000 web domains, the majority now fully disallow AI crawlers such as GPTBot andClaudeBot via robots.txt. The trend has accelerated from partial restrictions to outright blocks, and the crawl-to-referral ratios reveal the underlying tension: OpenAI's crawlers access approximately1,700 pages for every referral they return to publishers; Anthropic's ratio exceeds 73,000 to 1.
Patent databases, scientific publishers, and IP analytics platforms are among the most restrictive content categories. A Duke University study in 2025 found that several categories of AI-related crawlers never request robots.txt files at all. The practical consequence is that the knowledge gap between what a general-purpose model "knows" about the patent landscape and what actually exists in the patent record is widening with each training cycle. A landscape query that a general-purpose model partially answered in 2023 may return less useful information in 2026.
3.3 General-Purpose Models Lack Ontological Frameworks for Patent Analysis
A freedom-to-operate analysis is not a summarization task. It requires understanding claim scope, prosecution history, continuation and divisional chains, assignee normalization (a single company may appear under multiple entity names across patent records), priority dates versus filing dates versus publication dates, and the relationship between dependent and independent claims. It requires mapping the specific technical features of a proposed product against independent claim language—not keyword matching.
General-purpose models do not have these frameworks. They pattern-match against training data and produce outputs that adopt the format and tone of patent analysis without the underlying data infrastructure. The format is correct. The confidence is high. The coverage is incomplete in ways that are not visible to the user.
4. Comparative Output Quality
The following table summarizes the qualitative characteristics of each tool's response across the dimensions most relevant to an operational IP workflow.
5. Implications for R&D and IP Organizations
5.1 The Confidence Problem
The central risk identified by this study is not that general-purpose models produce bad outputs—it is that they produce incomplete outputs with high confidence. Each model delivered its results in a professional format with structured analysis, risk ratings, and strategic recommendations. At no point did any model indicate the boundaries of its knowledge or flag that its results represented a fraction of the available patent record. A practitioner receiving one of these outputs would have no signal that the analysis was incomplete unless they independently validated it against a comprehensive datasource.
This creates an asymmetric risk profile: the better the format and tone of the output, the less likely the user is to question its completeness. In a corporate environment where AI outputs are increasingly treated as first-pass analysis, this dynamic incentivizes under-investigation at precisely the moment when thoroughness is most critical.
5.2 The Diversification Illusion
It might be assumed that running the same query through multiple general-purpose models provides validation through diversity of sources. This study suggests otherwise. While the four tools returned different subsets of patents, all operated under the same structural constraints: training data rather than live patent databases, web-scraped content rather than structured IP records, and general-purpose reasoning rather than patent-specific ontological frameworks. Running the same query through three constrained tools does not produce triangulation; it produces three partial views of the same incomplete picture.
5.3 The Appropriate Use Boundary
General-purpose language models are effective tools for a wide range of tasks: drafting communications, summarizing documents, generating code, and exploratory research. The finding of this study is not that these tools lack value but that their value boundary does not extend to decisions that carry existential commercial risk.
Patent landscape analysis, freedom-to-operate assessment, and competitive intelligence that informs R&D investment decisions fall outside that boundary. These are workflows where the completeness and verifiability of the underlying data are not merely desirable but are the primary determinant of whether the analysis has value. A patent landscape that captures 10% of the relevant filings, regardless of how well-formatted or confidently presented, is a liability rather than an asset.
6. Test 2: Competitive Intelligence — Bio-Based Polyamide Patent Landscape
To assess whether the findings from Test 1 were specific to a single technology domain or reflected a broader structural pattern, a second query was submitted to all four tools. This query shifted from freedom-to-operate analysis to competitive intelligence, asking each tool to identify the top 10organizations by patent filing volume in bio-based polyamide synthesis from castor oil derivatives over the past three years, with summaries of technical approach, co-assignee relationships, and portfolio trajectory.
6.1 Query
6.2 Summary of Results
6.3 Key Differentiators
Verifiability
The most consequential difference in Test 2 was the presence or absence of verifiable evidence. Cypris cited over 100 individual patent filings with full patent numbers, assignee names, and publication dates. Every claim about an organization’s technical focus, co-assignee relationships, and filing trajectory was anchored to specific documents that a practitioner could independently verify in USPTO, Espacenet, or WIPO PATENT SCOPE. No general-purpose model cited a single patent number. Claude produced the most structured and analytically useful output among the public models, with estimated filing ranges, product names, and strategic observations that were directionally plausible. However, without underlying patent citations, every claim in the response requires independent verification before it can inform a business decision. ChatGPT and Co-Pilot offered thinner profiles with no filing counts and no patent-level specificity.
Data Integrity
ChatGPT’s response contained a structural error that would mislead a practitioner: it listed CathayBiotech as organization #5 and then listed “Cathay Affiliate Cluster” as a separate organization at #9, effectively double-counting a single entity. It repeated this pattern with Toray at #4 and “Toray(Additional Programs)” at #10. In a competitive intelligence context where the ranking itself is the deliverable, this kind of error distorts the landscape and could lead to misallocation of competitive monitoring resources.
Organizations Missed
Cypris identified Kingfa Sci. & Tech. (8–10 filings with a differentiated furan diacid-based polyamide platform) and Zhejiang NHU (4–6 filings focused on continuous polymerization process technology)as emerging players that no general-purpose model surfaced. Both represent potential competitive threats or partnership opportunities that would be invisible to a team relying on public AI tools.Conversely, ChatGPT included organizations such as ANTA and Jiangsu Taiji that appear to be downstream users rather than significant patent filers in synthesis, suggesting the model was conflating commercial activity with IP activity.
Strategic Depth
Cypris’s cross-cutting observations identified a fundamental chemistry divergence in the landscape:European incumbents (Arkema, Evonik, EMS) rely on traditional castor oil pyrolysis to 11-aminoundecanoic acid or sebacic acid, while Chinese entrants (Cathay Biotech, Kingfa) are developing alternative bio-based routes through fermentation and furandicarboxylic acid chemistry.This represents a potential long-term disruption to the castor oil supply chain dependency thatWestern players have built their IP strategies around. Claude identified a similar theme at a higher level of abstraction. Neither ChatGPT nor Co-Pilot noted the divergence.
6.4 Test 2 Conclusion
Test 2 confirms that the coverage and verifiability gaps observed in Test 1 are not domain-specific.In a competitive intelligence context—where the deliverable is a ranked landscape of organizationalIP activity—the same structural limitations apply. General-purpose models can produce plausible-looking top-10 lists with reasonable organizational names, but they cannot anchor those lists to verifiable patent data, they cannot provide precise filing volumes, and they cannot identify emerging players whose patent activity is visible in structured databases but absent from the web-scraped content that general-purpose models rely on.
7. Conclusion
This comparative analysis, spanning two distinct technology domains and two distinct analytical workflows—freedom-to-operate assessment and competitive intelligence—demonstrates that the gap between purpose-built R&D intelligence platforms and general-purpose language models is not marginal, not domain-specific, and not transient. It is structural and consequential.
In Test 1 (LLZO garnet electrolytes for Li-S batteries), the purpose-built platform identified more than three times as many patents as the best-performing general-purpose model and ten times as many as the lowest-performing one. Among the patents identified exclusively by the purpose-built platform were filings rated as Very High FTO risk that directly claim the proposed technology architecture. InTest 2 (bio-based polyamide competitive landscape), the purpose-built platform cited over 100individual patent filings to substantiate its organizational rankings; no general-purpose model cited as ingle patent number.
The structural drivers of this gap—reliance on training data rather than live patent feeds, the accelerating closure of web content to AI scrapers, and the absence of patent-specific analytical frameworks—are not transient. They are inherent to the architecture of general-purpose models and will persist regardless of increases in model capability or training data volume.
For R&D and IP leaders, the practical implication is clear: general-purpose AI tools should be used for general-purpose tasks. Patent intelligence, competitive landscaping, and freedom-to-operate analysis require purpose-built systems with direct access to structured patent data, domain-specific analytical frameworks, and the ability to surface what a general-purpose model cannot—not because it chooses not to, but because it structurally cannot access the data.
The question for every organization making R&D investment decisions today is whether the tools informing those decisions have access to the evidence base those decisions require. This study suggests that for the majority of general-purpose AI tools currently in use, the answer is no.
About This Report
This report was produced by Cypris (IP Web, Inc.), an AI-powered R&D intelligence platform serving corporate innovation, IP, and R&D teams at organizations including NASA, Johnson & Johnson, theUS Air Force, and Los Alamos National Laboratory. Cypris aggregates over 500 million data points from patents, scientific literature, grants, corporate filings, and news to deliver structured intelligence for technology scouting, competitive analysis, and IP strategy.
The comparative tests described in this report were conducted on March 27, 2026. All outputs are preserved in their original form. Patent data cited from the Cypris reports has been verified against USPTO Patent Center and WIPO PATENT SCOPE records as of the same date. To conduct a similar analysis for your technology domain, contact info@cypris.ai or visit cypris.ai.
United Airlines' "Relax Row" Looks Amazing. But Who Actually Owns the IP?
When United Airlines announced "Relax Row" — three adjacent economy seats with adjustable leg rests that raise to create a continuous lie-flat sleeping surface, complete with a mattress pad, blanket, and pillows — the aviation world took notice[1]. Slated for deployment on more than 200 of United's 787s and 777s, with up to 12 rows per aircraft, it represents one of the most ambitious economy cabin innovations ever attempted by a U.S. carrier[1].
But behind the glossy renders and enthusiastic social media rollout lies a thorny question that United hasn't publicly addressed: who actually owns the intellectual property behind this concept?
The answer, it turns out, is almost certainly not United Airlines.
The Skycouch Came First — By Over a Decade
The idea of economy seats with fold-up leg rests that create a flat sleeping surface across a row is not new. Air New Zealand pioneered this exact concept with its Economy Skycouch™, which has been in commercial service since approximately 2011[13]. The product works precisely the way United describes its Relax Row: passengers in a row of three economy seats can raise individual leg rests to seat-pan height, creating a continuous horizontal surface suitable for lying down[13].
Air New Zealand didn't just build the product — they patented it extensively. The foundational U.S. patent, US 9,132,918 B2, titled "Seating arrangement, seat unit, tray table and seating system," was granted in September 2015 and is assigned to Air New Zealand Limited[36]. The inventors — Victoria Anne Bamford, James Dominic France, Glen Wilson Porter, and Geoffrey Glen Suvalko — filed the earliest priority application in January 2009[36], giving the patent family protection extending approximately through 2029–2030.
The claims are remarkably broad. Claim 1 describes a row of adjacent seats where each seat includes a seat back, a seat pan, and a leg rest, with the leg rest moveable between a stored condition and a fully deployed condition where the seat pan and leg rest are substantially coplanar[36]. When deployed, the leg rests of adjacent seats become contiguous, and the combined surfaces cooperate to define a reconfigurable horizontal support surface that can assume T-shape, L-shape, U-shape, and I-shape configurations — allowing at least two adult passengers to recline parallel to the row direction[36].
The patent explicitly contemplates installation in an economy class section of an aircraft and in a class section that offers the lowest standard fare price per seat to customers[36]. In other words, this isn't a business class patent being stretched to cover economy — it was designed from the ground up to cover exactly what United is now proposing.
The IP Goes Deep
Air New Zealand's IP portfolio goes deeper than just the seating arrangement. A separate patent, EP 2509868, covers the specific leg rest mechanism itself — a sophisticated system using cam tracks, hydrolock pistons, synchronization cables, and detent formations that allow each leg rest to move independently between stowed, intermediate, and fully extended positions[39]. The mechanism is entirely self-supporting through the seat frame, requiring no support from the floor or the seat in front[39]. This level of mechanical detail creates additional layers of patent protection beyond the broad concept claims.
The patent family spans the globe, with filings and grants across the United States[33][34][36], Europe[35], Canada[50], Australia[48], Spain[41], France[40], Brazil[37], and other jurisdictions — a clear signal that Air New Zealand invested heavily in protecting this innovation worldwide.
Air New Zealand Has Licensed Before
Critically, Air New Zealand has not simply sat on this IP. The airline has actively licensed the Skycouch technology to other carriers. China Airlines adopted the concept for its 777-300ER fleet[23][126], and Brazilian carrier Azul licensed it for their "SkySofa" product[126]. The Skycouch represents a textbook case of patent protection leading to licensing of competitors[126].
This licensing history establishes two important facts. First, Air New Zealand treats this IP as a revenue-generating asset and actively monitors the market for potential licensees (or infringers). Second, there is a well-worn commercial path for airlines wanting to deploy this technology — they license it from Air New Zealand.
United's Silence on the IP Question
Here is where things get interesting. United's public communications about Relax Row make no mention of Air New Zealand, the Skycouch, or any licensing arrangement[1][138]. The airline's formal "Elevated" interior press release — a detailed document covering Polaris Studio suites, Premium Plus upgrades, economy screen sizes, and even red pepper flakes for onboard meals — contains zero references to economy lie-flat row technology or any third-party IP[138]. The Relax Row announcement appears to have been made separately through United's social media channels[1].
A thorough search of United Airlines' own patent portfolio reveals no filings covering the economy lie-flat row concept. United's seat-related patents focus on entirely different areas: business class herringbone seating with disabled access configurations[54][55], tray table indicators using magnetic ball mechanisms[72], and seat assignment automation systems[60]. Nothing in United's IP portfolio touches the fold-up leg rest mechanism or the convertible economy row concept.
So What's Going On?
There are several plausible explanations, and the truth likely lies in one of these scenarios.
Scenario 1: An undisclosed license. This is the most probable explanation. Licensing agreements between airlines are frequently confidential. Air New Zealand has demonstrated willingness to license the Skycouch, and United — as a sophisticated commercial entity — would almost certainly conduct freedom-to-operate analysis before committing to install this technology across 200+ widebody aircraft. A quiet licensing deal would explain both the functional similarity and the public silence.
Scenario 2: The seat manufacturer as intermediary. Airlines don't build their own seats — they purchase them from specialized manufacturers like Collins Aerospace (formerly B/E Aerospace), Safran Seats, Recaro, or others. The seat manufacturer supplying United's Relax Row hardware may hold a license or sub-license from Air New Zealand, meaning United is purchasing a licensed product rather than directly licensing the IP. This is common practice in the aircraft interiors supply chain.
Scenario 3: A design-around. While the end result looks identical to the Skycouch, the internal mechanism could differ. Air New Zealand's mechanism patent describes very specific cam-track, hydrolock, and synchronization systems[39]. A seat manufacturer could potentially engineer a leg rest that achieves the same functional result — raising to seat-pan height — using different internal mechanics. However, the broader seating arrangement patent covers the concept itself, not just the mechanism, making a pure design-around more difficult[36].
Notably, alternative approaches to economy lie-flat beds do exist. B/E Aerospace (now part of Collins Aerospace/RTX) holds recent patents describing economy seat rows convertible to beds using fundamentally different mechanisms — one where a lower portion of the backrest detaches and slides forward with the seat pan[92][95], and another where the backrest frame rotates forward to overlay the seat pan with a separate mattress placed on top[96]. These patents, filed from India in 2023 and granted in 2025, explicitly target the economy class cabin[92][96]. But from United's own images, the Relax Row appears to use fold-up leg rests — the Skycouch approach — rather than these backrest-based alternatives[1][2].
If There's No License, It Could Get Sticky
The fourth scenario — that United or its supplier is deploying this product without authorization — would create significant legal exposure. Air New Zealand's patent claims are broad, well-established, and have been maintained across multiple jurisdictions for over a decade[36][41][50]. The patent holder has demonstrated both willingness to license and awareness of the commercial value of this IP[126].
Consider the claim mapping. United describes three adjacent economy seats with adjustable leg rests that can each be raised or lowered to create a cozy lie-flat space[1]. Air New Zealand's patent claims cover a row of adjacent seats with leg rests moveable between stored and deployed conditions where the seat pan and leg rest become substantially coplanar, with adjacent leg rests becoming contiguous to form a reconfigurable horizontal support surface[36]. The visual evidence from United's announcement shows leg rests raised to seat level creating a continuous flat surface across the row[1][2] — a near-perfect overlay with the patent claims.
With the patent family not expiring until approximately 2029–2030, and United planning deployment across 200+ aircraft starting next year[1], the commercial stakes are enormous. An infringement finding could result in injunctive relief, royalty payments, or forced redesign — any of which would be extraordinarily costly and disruptive at the scale United is planning.
What to Watch For
The aviation IP community will be watching this space closely. Key indicators will include whether Air New Zealand makes any public statement acknowledging (or challenging) United's product, whether a licensing agreement surfaces in either company's financial disclosures, and whether the seat manufacturer behind Relax Row is identified — which could reveal whether the IP arrangement runs through the supply chain rather than directly between airlines.
For now, the most important takeaway is this: the concept behind United's splashy Relax Row announcement was invented, patented, and commercialized by Air New Zealand more than a decade ago. Whether United is paying for the privilege of using it, or betting that its implementation differs enough to avoid the patent claims, remains one of the more consequential unanswered questions in commercial aviation IP today.
This article was powered by Cypris Q, an AI agent that helps R&D teams instantly synthesize insights from patents, scientific literature, and market intelligence from around the globe. Discover how leading R&D teams use Cypris Q to monitor technology landscapes and identify opportunities faster - Book a demo
The information provided is for general informational purposes only and should not be construed as legal or professional advice.
Citations
[1] United Airlines Relax Row announcement (social media, March 2026)
[2] United Airlines Relax Row product images (March 2026)
[13] Air New Zealand. "Economy Skycouch – Long Haul."
[23] Executive Traveller. "Review: Air New Zealand's Skycouch seat (soon for China Airlines)."
[33] Air New Zealand Limited. Seating Arrangement, Seat Unit, Tray Table and Seating System. Patent No. US-20160031561-A1. Issued Feb 3, 2016.
[34] Air New Zealand Limited. Seating Arrangement, Seat Unit, Tray Table and Seating System. Patent No. US-20150203207-A1. Issued Jul 22, 2015.
[35] Air New Zealand Limited. Seating Arrangement, Seat Unit, Tray Table and Seating System. Patent No. EP-2391541-A1. Issued Dec 6, 2011.
[36] Air New Zealand Limited; Bamford, V.A.; France, J.D.; Porter, G.W.; Suvalko, G.G. Seating arrangement, seat unit, tray table and seating system. Patent No. US-9132918-B2. Issued Sep 14, 2015.
[37] Air New Zealand Limited. Seating arrangement, seat unit and passenger vehicle and method of setting up a passenger seat area. Patent No. BR-PI1008065-B1. Issued Jul 27, 2020.
[39] Air New Zealand Limited. A Seat and Related Leg Rest and Mechanism and Method Therefor. Patent No. EP-2509868-A1. Issued Oct 16, 2012.
[40] Air New Zealand Limited. Seating Arrangement, Seat Unit and Seating System. Patent No. FR-2941656-A3. Issued Aug 5, 2010.
[41] Air New Zealand Limited. Seating arrangement, seat unit, tray table and seating system. Patent No. ES-2742696-T3. Issued Feb 16, 2020.
[48] Air New Zealand Limited. Seating arrangement, seat unit, tray table and seating system. Patent No. AU-2010209371-B2. Issued Jan 13, 2016.
[50] Air New Zealand Limited. Seating Arrangement, Seat Unit, Tray Table and Seating System. Patent No. CA-2750767-C. Issued Apr 9, 2018.
[54] United Airlines, Inc. Passenger seating arrangement having access for disabled passengers. Patent No. US-11655037-B2. Issued May 22, 2023.
[55] United Airlines, Inc. Passenger seating arrangement having access for disabled passengers. Patent No. US-12291336-B2. Issued May 5, 2025.
[60] United Airlines, Inc. Method and system for automating passenger seat assignment procedures. Patent No. US-10185920-B2. Issued Jan 21, 2019.
[72] United Airlines, Inc. Tray table indicator. Patent No. US-12525316-B2. Issued Jan 12, 2026.
[92] B/E Aerospace, Inc. Row of passenger seats convertible to a bed. Patent No. US-12351317-B2. Issued Jul 7, 2025.
[95] B/E Aerospace, Inc. Row of Passenger Seats Convertible to a Bed. Patent No. US-20250051014-A1. Issued Feb 12, 2025.
[96] B/E Aerospace, Inc. Converting economy seat to full flat bed by dropping seat back frame. Patent No. US-12459650-B2. Issued Nov 3, 2025.
[126] Above the Law. "Coach Comfort: Myth Or The Future."
[138] United Airlines. "United Unveils the Elevated Aircraft Interior."